Pierce et al. analyzed the prognostic value of inflammatory markers in women with stage 0 to IIIA breast cancer in a multicenter, prospective, cohort study and found that CRP was associated with poor prognosis in women with breast cancer compared with the highest and lowest tertiles [HR 2.27; 95% CI 1.27–4.08]26. This evidence concerns the gene CRP and breast carcinoma.